SUBSCRIBE
SUBSCRIBE
News   Deals

Swiss Lonza Group Ltd. Eyes Stake in India Drug Firm, Aptuit Laurus in Deal Valued at $77 Million to $99 Million

March 24, 2010 | 
1 min read
Reuters -- Swiss drugs industry supplier Lonza (LONN.VX) is in talks to buy over 51 percent stake in India's Aptuit Laurus in a deal valued at $77 million to $99 million, the Business Standard reported on Wednesday.
Mergers & acquisitions Asia Europe
Lonza
MORE ON THIS TOPIC
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
December 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs
December 10, 2025
 · 
1 min read
 · 
Heather McKenzie
Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
December 10, 2025
 · 
1 min read
 · 
Annalee Armstrong
Hands holding red circle. Sensing energy between palms. Concept of human relation, togetherness, partnership, connection, contact or network. Design for banner, flyer, poster, cover or brochure.
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
December 10, 2025
 · 
7 min read
 · 
Dan Samorodnitsky